Rhenium-186 hydroxyethylidenediphosphonate (186Re HEDP) for the treatment of hemophilic arthropathy: First results

Clinical Journal of Pain

Volumn 23, Issue 7, 2007, Pages 612-618

  Bucerius, Jan ^a   Wallny, Thomas ^a   Brackmann, Hans Hermann ^a   Joe, Alexius Y ^a   Roedel, Roland ^a   Biersack, Hans Jürgen ^a   Palmedo, Holger ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Hemophilic arthropathy; Pain therapy; Radionuclide therapy; Rhenium 186 HEDP

Indexed keywords

ETIDRONIC ACID RE 186;

ADULT; ARTHRALGIA; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFICACY; HEMARTHROSIS; HEMOPHILIA; HUMAN; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SINGLE DRUG DOSE; SYMPTOM; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WHOLE BODY SCINTISCANNING;

ADULT; ARTHRALGIA; ARTHROPATHY, NEUROGENIC; ETIDRONIC ACID; HEMARTHROSIS; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PAIN MEASUREMENT; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 34548142954     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318123fd4e     Document Type: Article

References (35)

1. Luck JV, Silva M, Rodriguez-Merchan EC, et al. Hemophilic arthropathy. J Am Acad Orthop Surg. 2004;12:234-245.
2. Chang TJ, Mohamed S, Hambleton J. Hemophilic arthropathy: considerations in management. J Am Pediatr Med Assoc. 2001;91:406-414.
3. Brackmann HH, Effenberger W, Schwaab R, et al. Quality management and quality assurance in haemophilia care: a model at the Bonn haemophilia centre. Haemophilia. 2002;8:211-216.
4. Steven MM, Small M, Pinkerton L, et al. Non-steroidal anti-inflammatory drugs in haemophilic arthritis: a clinical and laboratory study. Haemostasis. 1985;15:204-209.
5. Shopnick RI, Brettler DB. Hemostasis: a clinical review of conservative and operative care. Clin Orthop Relat Res. 1996;328:34-38.
6. Rodriguez-Merchan EC, Wiedel JD. General principles and indications of synoviorthesis (medical synovectomy) in haemophilia. Haemophilia. 2001;7(suppl 2):6-10.
7. Palmedo H, Manka-Waluch A, Albers P, et al. Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: randomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate. J Clin Oncol. 2003;21:2869-2875.
8. Quirijnen JM, Han SH, Zonnenberg BA, et al. Efficacy of rhenium-186-HEDP etidronate in prostate cancer patients with metastatic bone pain. J Nucl Med. 1996;37:1511-1515.
9. Schoeneich G, Palmedo H, Dierke-Dzierzon C, et al. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results. Scand J Urol Nephrol. 1997;31:445-448.
10. Maxon HR, Deutsch EA, Thomas SR, et al. Rhenium-186 HEDP for treatment of multiple metastatic foci in bone: human distribution and dosimetric studies. Radiology. 1988;166:501-507.
11. Savio E, Gaudiano J, Robles AM, et al. Re-HEDP: pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose. BMC Nucl Med. 2001;1:2.
12. Maxon HR, Schroder LE, Thomas SR, et al. Rhenium-186 HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology. 1990;176:155-159.
13. Maxon HR, Schroder LE, Hertzberg VS, et al. Rhenium-186(Sn)-HEDP for treatment of painful osseous metastases: results of a double blind crossover comparison with placebo. J Nucl Med. 1991;32:1877-1881.
14. Porter AT, McEwan AJB, Powe JE, et al. Results of a randomized phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys. 1993;25:805-813.
15. Tu S, Millikan RE, Menigstu B, et al. Bone targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet. 2001;357:336-341.
16. Sciuto R, Festa A, Rea S, et al. Effects of low-dose cisplatin on strontium-89 therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J Nucl Med. 2002;43:79-86.
17. Palmedo H. Radionuklidtherapie. Der Nuklearmediziner. 2001;24:59-66.
18. Palmedo H, Rockstroh JK, Bangard M, et al. Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate (186 Re HEDP) after failed treatment with medication-initial results of a prospective study. Radiology. 2001;221:256-260.
19. Price DD, McGrath PA, Rafii A, et al. The validation of visual analogue scale as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45-56.
20. Sriwatanakul K, Kelvie W, Lasagna L, et al. Studies with different types of visual analog scale for measurement of pain. Clin Pharmacol Ther. 1983;34:234-239.
21. Wallny T, Hess L, Seuser A, et al. Pain status of patients with severe haemophilic arthropathy. Haemophilia. 2001;7:453-458.
22. Müller S, Kurth AA, Hovy L. Konservative Behandlungsmaßnahmen der haemophilen Arthropathie. Orthopaede. 1999;28:347-355.
23. Wallny T, Brackmann HH, Semper H, et al. Intra-articular hyaluronic acid in the treatment of haemophilic arthropathy of the knee. A clinical, radiological and sonographical assessment. Haemophilia. 2000;6:566-570.
24. Rodriguez-Merchan EC, Wiedel JD, Wallny T, et al. Elective orthopedic surgery for hemophilia patients with inhibitors: new opportunities. Semin Hematol. 2004;41(suppl 1):109-116.
25. Rodriguez-Merchan EC. Radionuclide synovectomy (Radiosynoviorthesis) in hemophilia: a very efficient and single procedure. Semin Thromb Hemost. 2003;29:97-100.
26. Dunn AL, Busch MT, Wyly JB, et al. Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol. Thromb Haemost. 2002;87:383-393.
27. Gratz S, Gobel D, Behr TM, et al. Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis. J Rheumatol. 1999;26:1242-1249.
28. Heim M, Goshen E, Amit Y, et al. Sinoviortesis with radioactive Yttrium in haemophilia: Israel experience. Haemophilia. 2001;7(suppl 2);36-39.
29. Rodriguez-Merchan EC, Jimenez-Yuste V, Villar A, et al. Yttrium-90 synoviorthesis for chronic haemophilic synovitis: Madrid experience. Haemophilia. 2001;7(suppl 2):34-35.
30. Silva M, Luck JV Jr, Siegel ME. 32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis. Haemophilia. 2001;7(suppl 2):40-49.
31. Fernandez-Palazzi F, Rivas S, Cibeira JL, et al. Radioactive synoviorthesis in hemophilic hemarthrosis. Materials, techniques, and dangers. Clin Orthop. 1996;328:14-18.
32. Taylor WJ, Corkil MM, Rajapaske CN. A retrospective review of yttrium-90 synovectomy in the treatment of knee arthritis. Br J Rheumatol. 1997;36:1100-1105.
33. Hildebrandt G, Jahns J, Hindemith M, et al. Effects of low dose radiation therapy on adjuvant induced arthritis in rats. Int J Radiat Biol. 2000;76:1143-1153.
34. Keilholz L, Seegenschmiedt MH, Kutzki D, et al. Periarthritis humeroscapularis (PHS). Indications, techniques and outcome of radiotherapy. Strahlenther Onkol. 1995;171:379-384.
35. Rodel F, Kamprad F, Sauer R, et al. Functional and molecular aspects of anti-inflammatory effects of low-dose radiotherapy. Strahlenther Onkol. 2002;178:1-9.